A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

A novel cell therapy approach using natural killer cells pre-complexed with a bispecific antibody, was safe and generated ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

Houston-based University of Texas MD Anderson Cancer Center and the University of Texas at Austin have launched a partnership in support of research projects designed to improve cancer prevention ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate ...

Uday R. Popat, MD, discusses promising findings from a phase 2 trial evaluating the JAK inhibitor itacitinib combined with ...

The University of Texas MD Anderson Cancer Center broke ground March 31 in Sugar Land on what will be the hospital system's largest Houston-area facility outside of the Texas Medical Center.

The University of Texas MD Anderson Cancer Center broke ground March 31 in Sugar Land on what will be the hospital system's largest Houston-area facility outside of the Texas Medical Center.

During a March Becker’s Hospital Review webinar sponsored by LeanTaaS, LeeAnn Mengel, RN, MBA, CMPE, FACHE, vice president and administrator of Baptist MD Anderson Cancer Center (Jacksonville ...

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Yago Nieto, Department of Stem Cell ...

Today Mediaplanet announces the launch of Blood Health, designed to raise awareness of blood disorders, cancers, and bleeding disorders. This wide-reaching initiative brings together some of the world ...

Researchers at MD Anderson Cancer Center at the University of Texas ... Results from an early-stage safety trial in B-cell lymphoma have not shown any incidence of cytokine release syndrome ...